Q4 2019 Evofem Biosciences Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Evofem Q4 and Year-end 2019 Financial Results Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker, Ms. Amy Raskopf. Please go ahead, ma'am.
Thank you. This is Amy Raskopf, Evofem Biosciences Head of Investor Relations. Today, we released our financial results for the fourth quarter and full year 2019. The press release and accompanying slides, which you can access through the webcast, are available on the Investor Relations section of the Evofem website.
Before I begin, I'd like to remind you that remarks on this call will contain forward-looking statements as stated on Slide 2. These forward-looking statements are made only as of today, March 12, 2020. Although the company may elect to update forward-looking statements from time to time in the future, we specifically disclaim any duty or obligation to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |